Posted on 12/24/20
First Batch of Moderna COVID-19 Vaccine Distributed in Va.
Virginia health districts and health care facilities statewide began receiving the newly approved Moderna COVID-19 vaccine this week, Virginia Department of Health announced Tuesday.About 140,000 doses . . .
Posted on 12/24/20
Is Johnson & Johnson Stock a Buy?
Although there's a lot to like about Johnson & Johnson (NYSE:JNJ), the company still has many qualities that might keep savvy investors on the sideline. A . . .
Posted on 12/24/20
Pfizer and BioNTech to Supply Feds With 100 Million Additional Doses of Coronavirus Vaccine
Still reeling from the coronavirus, the U.S. government has opted to double its take-up of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine. Both companies announced Wednesday . . .
Posted on 12/24/20
GBS Prices IPO
NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients . . .
Posted on 12/24/20
Senseonics Announces Business Update
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems . . .
Posted on 12/24/20
Today Marks the Start of COVID-19 Vaccinations at Maryland Nursing Homes
Vaccinations at nursing homes started today at Franklin Woods Center in Baltimore County. In preparation for Phase 1A of the state’s vaccination plan, the Maryland Department . . .
Posted on 12/24/20
Maryland’s Coronavirus Hospitalizations Reach Second Highest Point of Pandemic
As of Wednesday, 1,776 Marylanders are currently hospitalized due to coronavirus, the second highest number since the pandemic began.The highest amount of hospitalizations that Maryland has . . .
Posted on 12/23/20
Healthcare Services Acquisition Corporation Prices of Upsized $288 Million IPO
Healthcare Services Acquisition Corporation today announced the pricing of its upsized initial public offering of 28,800,000 units at a price of $10.00 per unit. The units are . . .
Posted on 12/23/20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
BOSTON, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for . . .
Posted on 12/23/20
Outlook Therapeutics Reports Financial Results for Fiscal Year 2020 and Provides Corporate Update
MONMOUTH JUNCTION, N.J., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a?late clinical-stage?biopharmaceutical company?working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg?for . . .
Posted on 12/23/20
Sale of Kantar Health Kicks Off Bain Makeover
Global researcher Kantar marked its first year under the control of Bain Capital by selling off its healthcare division to healthcare IT giant Cerner.The price tag . . .
Posted on 12/23/20
Is Pfizer's COVID Vaccine Growth Story Already Over?
No matter how you look at it, Pfizer (NYSE:PFE) has had a remarkable year in 2020. The big drugmaker made a critical decision early on to . . .
Posted on 12/23/20
What Pfizer Wants You to Know About Its COVID Vaccine
Last week, some Americans began receiving their first dose of BNT162b2, the COVID-19 vaccine developed by Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX). Soon after the vaccine began shipping, Pfizer . . .
Posted on 12/23/20
Kala Pharmaceuticals Should Have Limited Downside With Eysuvis Now Approved
Summary Kala Pharmaceuticals got its second ocular therapy, Eysuvis, approved on October 27.Peak sales estimates range from $500 million to over $1 billion due to its . . .
Posted on 12/23/20
Why Did Moderna Stock Fall on Good News Last Week?
Last week was a very good one for Moderna's (NASDAQ:MRNA) COVID-19 vaccine mRNA-1273. An advisory committee to the U.S. Food and Drug Administration (FDA) unanimously voted . . .
Posted on 12/23/20
Vertex Pharmaceuticals Enters New Partnership With RNA Expert Skyhawk Therapeutics
Vertex Pharmaceuticals (NASDAQ:VRTX) announced on Tuesday morning that it's entering a new partnership with a privately held Skyhawk Therapeutics, a biotech focused on discovering small-molecule drugs . . .
Posted on 12/23/20
GBS Prices of IPO
NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients and . . .
Posted on 12/22/20
Maryland Reports 51 More Coronavirus Deaths as Hospitalizations Rise
Maryland reported that 51 more residents have died from coronavirus-related complications, and there are 41 more Marylanders currently hospitalized with COVID-19 as of Tuesday morning.At least . . .
Posted on 12/22/20
Greenwich LifeSciences Closes of Public Offering of Common Stock
STAFFORD, Texas--(BUSINESS WIRE)--Greenwich LifeSciences, Inc. (Nasdaq: GLSI), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients . . .
Posted on 12/22/20
Acorn Bioventures Invests in Cyclacel Pharmaceuticals
BERKELEY HEIGHTS, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company developing innovative medicines based on cancer cell . . .
Posted on 12/22/20
SCYNEXIS Closes of $85 Million Public Offering of Common Stock
JERSEY CITY, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the closing of its previously announced underwritten public offering of common . . .
Posted on 12/22/20
Azara Healthcare and SPH Analytics’ Population Health Division Announce Merger
BOSTON--(BUSINESS WIRE)--Azara Healthcare, a leading provider of population health solutions to the community health market, and SPH Analytics, a leader in healthcare consumer experience measurement, engagement . . .
Posted on 12/22/20
Atriomx Health Secured $10 Million Series A Financing
Atriomx Health, a Menlo Park, California-based developer of novel, non-invasive solutions for the detection and characterization of the underlying disease mechanisms of atrial fibrillation and other . . .
Posted on 12/22/20
Coagulo Medical Technologies Announces $6.5 Million in Financing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Coagulo Medical Technologies, an MIT-born startup that has developed the world’s first precision-medicine platform for comprehensive and targeted blood clotting management, today announced it . . .
Posted on 12/22/20
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology
CHATHAM, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced an agreement whereby Tonix has acquired . . .

